Six of the world’s most prestigious public drug discovery organisations are joining forces in a bid to improve the conversion rate of basic research into much-needed new therapies.
Karimah Es Sabar, President and CEO of CDRD A new alliance has been set up to strengthen the international academic and not-for-profit drug discovery and commercialisation network and accelerate the translation of basic research into new drugs.
The Global Alliance of Drug Discovery and Development Centres (GADDDC) brings together the Centre for Drug Research and Development (CDRD) in Canada, Germany’s Lead Discovery Centre (LDC), The Scripps Research Institute, Scripps Florida, The Centre for Drug Design and Discovery at KU Leuven in Belgium, Medical Research Council Technology Ltd, UK and Cancer Research Technology, UK.
To read the original article: Leaders in academic tech transfer form new global innovation alliance - Science|Business
